Bipartisan Push to Overhaul Prior Authorization: What It Means for Providers, Payers, and Patients

Bipartisan Push to Overhaul Prior Authorization: What It Means for Providers, Payers, and Patients

Join us in revolutionizing healthcare administration. Explore how Neon’s AI solutions can help your organization overcome the administrative burden and unlock the full potential of your healthcare team. Contact us today to learn more.

Join us in revolutionizing healthcare administration. Explore how Neon’s AI solutions can help your organization overcome the administrative burden and unlock the full potential of your healthcare team. Contact us today to learn more.

Prior authorization (PA), the process insurers use to approve medical treatments or medications, is under scrutiny. Nineteen states have passed laws limiting stringent PA requirements due to delays in patient care. At the federal level, bipartisan support is growing for reform, with Republican Rep. Mark Green (TN) and Democratic Rep. Kim Schrier (WA) reintroducing the Medically Unnecessary Delays in Care Act of 2025. The bill requires peer-to-peer appeals for Medicare and Medicare Advantage denials to be handled by board-certified specialists in the same field as the prescribing physician.

Prior authorization (PA), the process insurers use to approve medical treatments or medications, is under scrutiny. Nineteen states have passed laws limiting stringent PA requirements due to delays in patient care. At the federal level, bipartisan support is growing for reform, with Republican Rep. Mark Green (TN) and Democratic Rep. Kim Schrier (WA) reintroducing the Medically Unnecessary Delays in Care Act of 2025. The bill requires peer-to-peer appeals for Medicare and Medicare Advantage denials to be handled by board-certified specialists in the same field as the prescribing physician.

State and Federal Changes

Key Provisions

The legislation ensures specialists, not generalists, review PA appeals. For example, only an orthopedist would evaluate a knee replacement appeal, addressing concerns about inappropriate denials. Rep. Green stated, “We’ve got to let doctors focus on treating patients. This bill will reduce frustration in the prior authorization process for Medicare recipients.”

Implications for Payers

Requiring specialist-led appeals could raise costs for insurers, who often rely on generalist staff for PA reviews. Payers may need to hire or contract specialists, potentially slowing appeals if expertise is limited. This could force payers to rethink PA workflows.

Balancing Reform and Oversight

PA reform is widely supported but raises concerns about over-prescription by some providers if restrictions ease too much. Without checks, this could increase healthcare costs or lead to unnecessary treatments, challenging PA’s role in utilization control.

Key Provisions

The legislation ensures specialists, not generalists, review PA appeals. For example, only an orthopedist would evaluate a knee replacement appeal, addressing concerns about inappropriate denials. Rep. Green stated, “We’ve got to let doctors focus on treating patients. This bill will reduce frustration in the prior authorization process for Medicare recipients.”

Implications for Payers

Requiring specialist-led appeals could raise costs for insurers, who often rely on generalist staff for PA reviews. Payers may need to hire or contract specialists, potentially slowing appeals if expertise is limited. This could force payers to rethink PA workflows.

Balancing Reform and Oversight

PA reform is widely supported but raises concerns about over-prescription by some providers if restrictions ease too much. Without checks, this could increase healthcare costs or lead to unnecessary treatments, challenging PA’s role in utilization control.

The Future of Prior Authorization

PA is moving toward efficiency and patient focus, driven by these trends:

  1. Automation

    • AI and electronic health record integration can streamline PA, speeding approvals for routine cases. CMS is pushing electronic PA to reduce delays, but systems must ensure clinical accuracy.

  2. Regulatory Oversight

    • Future reforms may mandate faster approvals or limit PA’s scope, easing provider burdens but challenging payers’ cost controls.

  3. Value-Based Care

    • PA may shift to align with outcomes-based metrics, reducing volume but requiring payer-provider collaboration to ensure appropriate care.

Second-Order Effects

  1. Cost Increases

    • Specialist-led appeals could raise payer costs, potentially increasing premiums. Higher utilization may also drive up healthcare spending.

  2. Provider Autonomy

    • Less PA oversight may enable over-prescription by some providers. Payers could use audits or analytics to monitor patterns.

  3. Patient Access

    • Faster PA processes could improve outcomes and adherence but may strain resources like specialist availability.

  4. Payer-Provider Dynamics

    • Reforms may strain relationships, with payers tightening other controls like formularies to offset reduced PA leverage.

PA is moving toward efficiency and patient focus, driven by these trends:

  1. Automation

    • AI and electronic health record integration can streamline PA, speeding approvals for routine cases. CMS is pushing electronic PA to reduce delays, but systems must ensure clinical accuracy.

  2. Regulatory Oversight

    • Future reforms may mandate faster approvals or limit PA’s scope, easing provider burdens but challenging payers’ cost controls.

  3. Value-Based Care

    • PA may shift to align with outcomes-based metrics, reducing volume but requiring payer-provider collaboration to ensure appropriate care.

Second-Order Effects

  1. Cost Increases

    • Specialist-led appeals could raise payer costs, potentially increasing premiums. Higher utilization may also drive up healthcare spending.

  2. Provider Autonomy

    • Less PA oversight may enable over-prescription by some providers. Payers could use audits or analytics to monitor patterns.

  3. Patient Access

    • Faster PA processes could improve outcomes and adherence but may strain resources like specialist availability.

  4. Payer-Provider Dynamics

    • Reforms may strain relationships, with payers tightening other controls like formularies to offset reduced PA leverage.

PA, Health Providers and Patients

The Medically Unnecessary Delays in Care Act and state reforms aim to streamline prior authorization, prioritizing patient access. While these changes could reduce delays, they risk higher costs and overutilization. Automation and value-based care will shape PA’s future, but collaboration among payers, providers, and regulators is key to balancing access and accountability.

The Medically Unnecessary Delays in Care Act and state reforms aim to streamline prior authorization, prioritizing patient access. While these changes could reduce delays, they risk higher costs and overutilization. Automation and value-based care will shape PA’s future, but collaboration among payers, providers, and regulators is key to balancing access and accountability.

NEWSLETTER

@ 2025 Neon Health (Belay, Inc).

AI-powered patient access automation

for leading pharma enterprises.

Terms of service

Cookie policy

NEWSLETTER

@ 2025 Neon Health (Belay, Inc).

AI-powered patient access automation for leading pharma enterprises.

Terms of service

Cookie policy

NEWSLETTER

@ 2025 Neon Health (Belay, Inc).

AI-powered patient access automation

for leading pharma enterprises.

Terms of service

Cookie policy